| dc.contributor.author |
Helmold, Matthias |
|
| dc.contributor.author |
Amann, Ralf |
|
| dc.date.accessioned |
2025-10-20T07:27:55Z |
|
| dc.date.available |
2025-10-20T07:27:55Z |
|
| dc.date.issued |
2025 |
|
| dc.identifier.issn |
1052-9276 |
|
| dc.identifier.uri |
http://hdl.handle.net/10900/171442 |
|
| dc.language.iso |
en |
de_DE |
| dc.publisher |
Hoboken : Wiley |
de_DE |
| dc.relation.uri |
http://dx.doi.org/10.1002/rmv.70038 |
de_DE |
| dc.subject.ddc |
570 |
de_DE |
| dc.subject.ddc |
610 |
de_DE |
| dc.title |
Advancing ORFV-Based Therapeutics to the Clinical Stage |
de_DE |
| dc.type |
Article |
de_DE |
| utue.quellen.id |
20250630000000_00635 |
|
| utue.personen.roh |
Helmold, Matthias |
|
| utue.personen.roh |
Amann, Ralf |
|
| dcterms.isPartOf.ZSTitelID |
Reviews in Medical Virology |
de_DE |
| dcterms.isPartOf.ZS-Issue |
Article e70038 |
de_DE |
| dcterms.isPartOf.ZS-Volume |
35 (3) |
de_DE |
| utue.fakultaet |
04 Medizinische Fakultät |
de_DE |